San Diego, CA, United States of America

Paul Sheahan

USPTO Granted Patents = 5 



Average Co-Inventor Count = 13.9

ph-index = 3

Forward Citations = 95(Granted Patents)


Location History:

  • San Diego, CA (US) (2009 - 2011)
  • Hopkinton, MA (US) (2004 - 2013)

Company Filing History:


Years Active: 2004-2013

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Inventor Paul Sheahan

Introduction

Paul Sheahan is an accomplished inventor based in San Diego, California. With five patents to his name, Sheahan has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of tetracycline compounds. His work has broad implications for medical treatments, particularly in addressing bacterial infections and various neoplasms.

Latest Patents

Among his notable inventions are two recent patents focused on novel tetracycline derivatives. The first is a patent for **7-substituted tetracycline compounds**, which are designed to treat several tetracycline compound-responsive states. These compounds not only target bacterial infections but also have potential application in blocking tetracycline efflux and modulating gene expression. The second patent is for **9-substituted minocycline compounds**, which share similar applications and benefits, reflecting Sheahan's dedication to advancing pharmaceutical solutions for complex health issues.

Career Highlights

Throughout his career, Paul Sheahan has been affiliated with prominent organizations such as Paratek Pharmaceuticals, Inc. and Tufts College. His roles in these institutions have provided him with a strong foundation to explore innovative pharmaceutical applications. His expertise in drug formulation and development has led to the creation of groundbreaking compounds aimed at improving patient treatment outcomes.

Collaborations

Sheahan has also collaborated with esteemed colleagues, including Mark L. Nelson and Roger Frechette. These partnerships illustrate the importance of teamwork in the innovation process, enabling the sharing of knowledge and expertise that often leads to significant breakthroughs.

Conclusion

In summary, Paul Sheahan's inventive work, particularly in the development of tetracycline compounds, represents a substantial contribution to the field of pharmaceuticals. His five patents highlight his commitment to advancing medical science and enhancing treatment options for various diseases. The collaborative efforts with other professionals underline the value of partnerships in fostering innovation and improving healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…